Aurigene Oncology Limited

Aurigene Oncology Limited

Biotechnology Research

Conquering Cancer

About us

Founded in 2002, we are a clinical stage biotech company committed to bringing novel and effective therapeutics for the treatment of cancer. We leverage our deep expertise in oncology focused drug discovery and development to bring novel therapeutics to cancer patients. Since inception, we have discovered 20 novel chemical entities for clinical development. We have out-licensed several of these to pharmaceutical and biotech companies, while advancing a few on our own. We have built comprehensive drug discovery and development capabilities, nurtured a growing team of passionate scientists, and collaborated with partners across the world.

Website
www.aurigene.com
Industry
Biotechnology Research
Company size
201-500 employees
Type
Privately Held
Founded
2002
Specialties
Oncology, Drug Research and Development, Innovative therapeutics, Small Molecules, Antibodies, Cell therapy, Clinical Stage Biotech, Targeted protein Degradation, Immuno-oncology, Precision Medicine, Kinases, Epigenetics, DNA repair, and Peptides and Peptidomemitics

Employees at Aurigene Oncology Limited

Updates

Similar pages